Evidence map›Paper›PMID 39903109›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Impact of

Kengo Shibata, Cheng Chen, Xin You Tai, Sanjay G Manohar, Masud Husain

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Amyloid-Frontiers in aging neuroscience · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kengo ShibataNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom.ORCID 0000-0002-6156-426X
Cheng ChenDepartment of Experimental Psychology, University of Oxford, Oxford OX2 6GG, United Kingdom.
Xin You TaiNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom.
Sanjay G ManoharNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom.
Masud HusainNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom.ORCID 0000-0002-6850-9255

Funding

UKRI | Medical Research Council (MRC) MR/P00878XWellcome TrustWellcome Trust (WT) 206330/Z/17/Z
6 · The paper itself

Abstract

The effects of apolipoprotein E (

Indexed as

AgingApolipoproteins ECognitive DysfunctionGlucuronidaseAdultAgedApolipoprotein E4BrainCognitionFemaleGenotypeHumansKlotho ProteinsMaleMiddle AgedSex FactorsApoE protein, humanApolipoprotein E4Apolipoproteins EGlucuronidaseKlotho ProteinsKL protein, humanagingantagonistic pleiotropyapolipoprotein ε (apoe)cognitionklotho

Identifiers

PMID39903109
PMCPMC11831164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.